TPM3P5: A Potential Drug Target Or Biomarker (G644330)

Target Name: TPM3P5

NCBI ID: G644330

TPM3P5

Other Name(s): tropomyosin 3 pseudogene 5 | Tropomyosin 3 pseudogene 5

TPM3P5: A Potential Drug Target Or Biomarker

TPM3P5, also known as tropomyosin 3 pseudogene 5, is a gene that has been identified as a potential drug target or biomarker for several diseases, including heart failure, hypertension, and cancer. The protein encoded by this gene is involved in the regulation of muscle contractions and has been shown to play a role in the development and progression of several diseases.

The discovery of TPM3P5 as a potential drug target or biomarker began with the identification of its involvement in the development of heart failure. Studies have shown that individuals with certain genetic variations in the TPM3P5 gene are at an increased risk of developing heart failure. This suggests that TPM3P5 may be a useful target for developing new treatments for heart failure.

Another potential application of TPM3P5 as a drug target is its role in hypertension. Studies have shown that individuals with certain genetic variations in the TPM3P5 gene are at an increased risk of developing hypertension. This suggests that TPM3P5 may be a useful target for developing new treatments for hypertension.

In addition to its potential as a drug target, TPM3P5 has also been shown to be a potential biomarker for several diseases. For example, studies have shown that individuals with certain genetic variations in the TPM3P5 gene may have an increased risk of developing cancer. This suggests that TPM3P5 may be a useful biomarker for identifying individuals at risk for cancer.

Another potential application of TPM3P5 as a drug target is its role in the regulation of muscle contractions. Studies have shown that individuals with certain genetic variations in the TPM3P5 gene have altered muscle contractions and may be at an increased risk of developing certain diseases, such as muscular dystrophy. This suggests that TPM3P5 may be a useful target for developing new treatments for these diseases.

In conclusion, TPM3P5 is a gene that has been identified as a potential drug target or biomarker for several diseases. Its involvement in the regulation of muscle contractions and its association with the development and progression of heart failure, hypertension, and cancer make it an attractive target for research and development of new treatments. Further studies are needed to fully understand the role of TPM3P5 as a drug target and biomarker.

Protein Name: Tropomyosin 3 Pseudogene 5

The "TPM3P5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TPM3P5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets